CrunchBase is hiring! Check out our open positions →
Register | Login or

General Information

Websitetricapital.co.uk
Phone01896-820631
Email
Employees

Funds

Offices

United Kingdom
St Dunstans House, High Street
Melrose, TD6 9RU
GBR

People

Chairman
Vice Chairman

Tags

Tweed Renaissance Investors Capital

With investment deals valued at more than £3 million under its belt, Tweed Renaissance Investors Capital (TRI Cap) is one of Scotland’s newest business angel syndicates and also one of its most dynamic. For both investors and those seeking investment. TRI Cap is very firmly on the map. Since its launch in 2005 both membership and deals have maintained a keen pace, and they continue to actively seek both. Read their News pages to gain a snapshot of the organisation and the deals TRI Cap members have been involved in. In truth, TRI Cap is mature beyond its years, with many decades of first-rate entrepreneurial, financial and management experience round their board room table. Visit their Members page to learn a little more about their people.

Milestones

Investments

Company Date Round Size Participants
MGB Biopharma 3/10Venture Round$3.03M4
Syntropharma 12/09Venture Round$640k3
Exterity 12/08Venture Round£1.1M3
Factonomy 5/08Series B$1.69M4
Powerphotonic 1/08Venture Round$979k2
Syntropharma 11/06Series A£1M3

Videos

Sources

  1. Funding secured totalling almost £2M from angel syndicate (mgb-biopharma.com) [edit]
  2. Syntropharma Collects Follow-On Funding For Transdermal Patch (fis.dowjones.com) [edit]
  3. Exterity raises £1.1m in funding (news.techex.co.uk) [edit]
  4. Factonomy boosted by near£1m funding (business.scotsman.com) [edit]
  5. PowerPhotonic Ltd Secures Funding (dcconsult.co.uk) [edit]
  6. Syntropharma Secures Funding (growthbusiness.co.uk) [edit]
Edit This Page
Last Edited 7/22/10

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy